Anaconda Biomed Raises $56 Million To Advance Stroke Treatment Technology And Complete Pivotal Clinical Trial
By Amit Chowdhry ● Sep 24, 2026
Anaconda Biomed, a medical technology company based in Barcelona, Spain, and Marin, California, has secured $56 million in financing led by Omega Funds, with participation from new investor Spain's Co-investment Fund (FOCO), managed by COFIDES, and existing investors Asabys, Ysios Capital, and CDTI through its SICC Innvierte initiative. The financing will support the completion of the company's ATHENA pivotal clinical trial, continued development of its neurovascular device portfolio, and efforts to secure additional regulatory approvals internationally.